169 related articles for article (PubMed ID: 6378794)
1. Phenotypic distinctiveness of Staphylococcus aureus strains associated with toxic shock syndrome.
Todd JK; Franco-Buff A; Lawellin DW; Vasil ML
Infect Immun; 1984 Aug; 45(2):339-44. PubMed ID: 6378794
[TBL] [Abstract][Full Text] [Related]
2. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates.
Bergdoll MS; Crass BA; Reiser RF; Robbins RN; Davis JP
Lancet; 1981 May; 1(8228):1017-21. PubMed ID: 6112412
[TBL] [Abstract][Full Text] [Related]
3. Vaginal isolates of Staphylococcus aureus associated with toxic shock syndrome.
Barbour AG
Infect Immun; 1981 Aug; 33(2):442-9. PubMed ID: 6456228
[TBL] [Abstract][Full Text] [Related]
4. Crystal violet binding, cell surface properties and extracellular enzyme profiles of Staphylococcus aureus producing toxic shock syndrome toxin-1.
Naidu AS; Jimenez J; Rollof J; Aleljung P; Nilsson-Ehle P; Larsson L; Hedström SA
Zentralbl Bakteriol; 1989 May; 271(1):11-21. PubMed ID: 2669786
[TBL] [Abstract][Full Text] [Related]
5. Distribution and expression of toxic shock syndrome toxin 1 gene among Staphylococcus aureus isolates of toxic shock syndrome and non-toxic shock syndrome origin.
Bonventre PF; Weckbach L; Harth G; Haidaris C
Rev Infect Dis; 1989; 11 Suppl 1():S90-5. PubMed ID: 2928656
[TBL] [Abstract][Full Text] [Related]
6. Determination by western blot (immunoblot) of seroconversions to toxic shock syndrome (TSS) toxin 1 and enterotoxin A, B, or C during infection with TSS- and non-TSS-associated Staphylococcus aureus.
Whiting JL; Rosten PM; Chow AW
Infect Immun; 1989 Jan; 57(1):231-4. PubMed ID: 2909490
[TBL] [Abstract][Full Text] [Related]
7. Toxic Shock Syndrome Toxin 1 Evaluation and Antibiotic Impact in a Transgenic Model of Staphylococcal Soft Tissue Infection.
Sharma H; Turner CE; Siggins MK; El-Bahrawy M; Pichon B; Kearns A; Sriskandan S
mSphere; 2019 Oct; 4(5):. PubMed ID: 31597722
[TBL] [Abstract][Full Text] [Related]
8. Production of staphylococcal enterotoxin F and pyrogenic exotoxin C by Staphylococcus aureus isolates from toxic shock syndrome-associated sources.
Bonventre PF; Weckbach L; Staneck J; Schlievert PM; Thompson M
Infect Immun; 1983 Jun; 40(3):1023-9. PubMed ID: 6189784
[TBL] [Abstract][Full Text] [Related]
9. Enterotoxin production by strains of Staphylococcus aureus isolated from clinical and non-clinical specimens with special reference to enterotoxin F and toxic shock syndrome.
de Nooij MP; van Leeuwen WJ; Notermans S
J Hyg (Lond); 1982 Dec; 89(3):499-505. PubMed ID: 6218196
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the hemolytic activity of Staphylococcus aureus strains associated with toxic shock syndrome.
Chow AW; Gribble MJ; Bartlett KH
J Clin Microbiol; 1983 Mar; 17(3):524-8. PubMed ID: 6841587
[TBL] [Abstract][Full Text] [Related]
11. Induction of interleukin-1 by strains of Staphylococcus aureus from patients with nonmenstrual toxic shock syndrome.
Parsonnet J; Gillis ZA; Pier GB
J Infect Dis; 1986 Jul; 154(1):55-63. PubMed ID: 3486924
[TBL] [Abstract][Full Text] [Related]
12. Enterotoxins and toxic-shock syndrome toxin-1 in non-enteric staphylococcal disease.
Marples RR; Wieneke AA
Epidemiol Infect; 1993 Jun; 110(3):477-88. PubMed ID: 8519313
[TBL] [Abstract][Full Text] [Related]
13. Toxic-shock syndrome: a commentary and review of the characteristics of Staphylococcus aureus strains.
Chesney PJ
Infection; 1983; 11(4):181-8. PubMed ID: 6352506
[TBL] [Abstract][Full Text] [Related]
14. Binding of type-I and type-II collagens to Staphylococcus aureus strains isolated from patients with toxic shock syndrome compared to other staphylococcal infections.
Naidu AS; Ekstrand J; Wadström T
FEMS Microbiol Immunol; 1989 Mar; 1(4):219-27. PubMed ID: 2629906
[TBL] [Abstract][Full Text] [Related]
15. Influence of focal growth conditions on the pathogenesis of toxic shock syndrome.
Todd JK; Todd BH; Franco-Buff A; Smith CM; Lawellin DW
J Infect Dis; 1987 Apr; 155(4):673-81. PubMed ID: 3546518
[TBL] [Abstract][Full Text] [Related]
16. Recurrent nonmenstrual toxic shock syndrome: clinical manifestations, diagnosis, and treatment.
Andrews MM; Parent EM; Barry M; Parsonnet J
Clin Infect Dis; 2001 May; 32(10):1470-9. PubMed ID: 11317249
[TBL] [Abstract][Full Text] [Related]
17. [Lethal, non-menstrual toxic shock syndrome associated with Staphylococcus aureus sepsis].
Raumanns J; Kaufhold A; Behrendt W; Peters G
Anaesthesist; 1995 Dec; 44(12):869-74. PubMed ID: 8594962
[TBL] [Abstract][Full Text] [Related]
18. Genotypic characterization of toxic shock syndrome toxin-1-producing strains of Staphylococcus aureus isolated in the Czech Republic.
Hrstka R; Růzicková V; Petrás P; Pantůcek R; Rosypal S; Doskar J
Int J Med Microbiol; 2006 Feb; 296(1):49-54. PubMed ID: 16423687
[TBL] [Abstract][Full Text] [Related]
19. Infection with Staphylococcus aureus producing toxic shock syndrome (TSS) toxin-1 without TSS.
Nadal D; Hunziker UA; Bauersfeld U; Pfister H; Hitzig WH
Eur J Pediatr; 1989 Jan; 148(4):318-9. PubMed ID: 2651130
[TBL] [Abstract][Full Text] [Related]
20. Microbiology of toxic shock syndrome: overview.
See RH; Chow AW
Rev Infect Dis; 1989; 11 Suppl 1():S55-60. PubMed ID: 2648541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
